No response to antihypertensive therapy: Consider non-adherence;Geen reactie op antihypertensieve therapie: Denk aan therapieontrouw

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 10, 2007, Pages 569-573

  Braam, R L ^a   Van Uum, S H M ^b   Lenders, J W M ^c   Thien, Th ^c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CHLORTALIDONE; ENALAPRIL; HYDROCHLOROTHIAZIDE; ISOSORBIDE DINITRATE; LEVOMEPROMAZINE; NIFEDIPINE; OXAZEPAM;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG INFORMATION; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; TREATMENT RESPONSE;

ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; TREATMENT FAILURE;

EID: 33947666566     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sabaté E. Adherence to long-term therapies. Evidence for action. Genève: World Health Organization; 2003.
2. Wright EC. Non-compliance - or how many aunts has Matilda? Lancet. 1993;342:909-13.
3. Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: Johns Hopkins University Press; 1979.
4. Marinker M. Writing prescriptions is easy. BMJ. 1997;314:747-8.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
6. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112:1651-62.
7. Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet. 1994;27:202-15.
8. Kaplan NM. Treatment of hypertension: drug therapy. In: Kaplan NM, editor. Clinical hypertension. Ch 7. 7th ed. Baltimore: Williams & Wilkins; 1998. p. 181-264.
9. Kalmthout PM van, Vree TB, Thien Th. Therapietrouw en kaliumgehalte in het plasma bij patiënten behandeld met chloortalidon. Ned Tijdschr Geneeskd. 1983;127:192-5.
10. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-10.
11. Feinstein AR, On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377-8.
12. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Non-compliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-11.
13. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-4.
14. Düsing R, Weisser B, Mengden T, Vetter H. Changes in antihypertensive therapy - the role of adverse effects and compliance. Blood Press. 1998;7:313-5.
15. Beckman AGK, Parker MG, Thorslund M. Can elderly people take their medicine? Patient Educ Couns. 2005;59:186-91.
16. Pignone MP, DeWalt DA. Literacy and health outcomes: is adherence the missing link? J Gen Intern Med. 2006;21:896-7.
17. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figueravon Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, et al. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. Compliance Group of the Spanish Society of Hypertension (SEE). J Hypertens. 2006;24:169-75.
18. Allen H. Promoting compliance with antihypertensive medication. Br J Nurs. 1998;7:1252-8.
19. Rudd P, Miller NH, Kaufman J, Kraemer HC, Bandura A, Greenwald G, et al. Nurse management for hypertension. A systems approach. Am J Hypertens. 2004;17:921-7.
20. Kessels RPC. Patients' memory for medical information. J R Soc Med. 2003;96:219-22.